| Further characterization of clinical and laboratory features occurring in VEXAS syndrome in a large‐scale analysis of multicenter case‐series of 116 French patients S Georgin‐Lavialle, B Terrier, AF Guedon, M Heiblig, T Comont, E Lazaro, ... British Journal of Dermatology, 2021 | 232* | 2021 |
| Real-world validation of molecular international prognostic scoring system for myelodysplastic syndromes E Sauta, M Robin, M Bersanelli, E Travaglino, M Meggendorfer, LP Zhao, ... Journal of Clinical Oncology 41 (15), 2827-2842, 2023 | 55 | 2023 |
| A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML A Mekinian, LP Zhao, S Chevret, K Desseaux, L Pascal, T Comont, ... Leukemia 36 (11), 2739-2742, 2022 | 51 | 2022 |
| Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease LP Zhao, M Boy, C Azoulay, E Clappier, M Sébert, L Amable, J Klibi, ... Leukemia 35 (9), 2720-2724, 2021 | 42 | 2021 |
| Prevalence of UBA1 mutations in MDS/CMML patients with systemic inflammatory and auto-immune disease LP Zhao, B Schell, M Sébert, R Kim, P Lemaire, M Boy, S Mathis, ... Leukemia 35 (9), 2731-2733, 2021 | 32 | 2021 |
| Clinical and pathological features of cutaneous manifestations in VEXAS syndrome: a multicenter retrospective study of 59 cases È Zakine, L Papageorgiou, R Bourguiba, A Mekinian, B Terrier, ... Journal of the American Academy of Dermatology 88 (4), 917-920, 2023 | 28 | 2023 |
| Impact of NFE2 mutations on AML transformation and overall survival in patients with myeloproliferative neoplasms C Marcault, LP Zhao, N Maslah, E Verger, R Daltro de Oliveira, ... Blood, The Journal of the American Society of Hematology 138 (21), 2142-2148, 2021 | 26 | 2021 |
| Clinical, pathological, and molecular features of myelodysplasia cutis J Delaleu, R Kim, LP Zhao, A de Masson, MD Vignon-Pennamen, ... Blood, The Journal of the American Society of Hematology 139 (8), 1251-1253, 2022 | 22 | 2022 |
| Interferon-alpha (IFN) therapy discontinuation is feasible in myeloproliferative neoplasm (MPN) patients with complete hematological remission RD De Oliveira, J Soret-Dulphy, LP Zhao, C Marcault, N Gauthier, ... Blood 136, 35-36, 2020 | 22 | 2020 |
| Nationwide survey in France on the use of romiplostim in patients with refractory severe aplastic anemia LP Zhao, F Sicre De Fontbrune, A Contejean, J Abraham, L Terriou, ... Bone Marrow Transplantation 54 (7), 1161-1163, 2019 | 19 | 2019 |
| Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation M Boy, V Bisio, LP Zhao, F Guidez, B Schell, E Lereclus, G Henry, ... Nature communications 14 (1), 588, 2023 | 14 | 2023 |
| A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study G Maggioni, M Bersanelli, E Travaglino, AA Piérola, A Kasprzak, ... The Lancet Haematology 10 (2), e117-e128, 2023 | 9 | 2023 |
| SF3B1 mutations in the driver clone increase the risk of evolution to myelofibrosis in patients with myeloproliferative neoplasms (MPN) LP Zhao, RD De Oliveira, C Marcault, J Soret, N Gauthier, E Verger, ... Blood 136, 1, 2020 | 8 | 2020 |
| Metagenomic next-generation sequencing restores the diagnosis of a rare infectious complication of B cell depletion M Garzaro, LP Zhao, N De Castro, S Mercier-Delarue, F Camelena, ... European Journal of Clinical Microbiology & Infectious Diseases 41 (10 …, 2022 | 6 | 2022 |
| Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification H Pasquer, R Daltro de Oliveira, L Vasseur, J Soret-Dulphy, N Maslah, ... Leukemia 38 (2), 326-339, 2024 | 5 | 2024 |
| Multi-modal analysis and federated learning approach for classification and personalized prognostic assessment in myeloid neoplasms S D'Amico, L Dall'Olio, C Rollo, P Alonso, I Prada-Luengo, D Dall'Olio, ... Blood 140 (Supplement 1), 9828-9830, 2022 | 5 | 2022 |
| CD38 targeting in aggressive, treatment-refractory cutaneous T-cell lymphomas M Battistella, LP Zhao, G Dobos, C Ram-Wolff, I Madelaine, JC Bories, ... The Journal of investigative dermatology 143 (7), 1329-1332. e3, 2023 | 4 | 2023 |
| What role for somatic mutations in systemic inflammatory and autoimmune diseases associated with myelodysplastic neoplasms and chronic myelomonocytic leukemias? LP Zhao, M Sébert, A Mékinian, O Fain, M Espéli, K Balabanian, N Dulphy, ... Leukemia 37 (6), 1186-1190, 2023 | 4 | 2023 |
| Myeloproliferative Neoplasms (MPN) clonal evolution landscape and its impact on patients' prognosis LP Zhao, M Cazaux, N Maslah, RD De Oliveira, E Verger, J Soret-Dulphy, ... Blood 138, 317, 2021 | 4 | 2021 |
| MDS/CMML with TET2 or IDH mutation Are Associated with Systemic Inflammatory and Autoimmune Diseases (SIAD) and T Cell Dysregulation LP Zhao, M Boy, C Azoulay, E Clappier, M Sébert, L Amable, J Klibi, ... Blood 136, 31-32, 2020 | 4 | 2020 |
